Korea Narihiko Yoshii, president of Mitsubishi Tanabe Pharma Korea unveils the value that they are bringing to Korean patients by utilising legislation regarding orphan drugs to fast track the market entry of their products. Yoshii also provides his assessment of how low drug pricing is indirectly affecting the decisions of Mitsubishi…
France Eric Goupil, CEO of Unither Pharmaceuticals, discusses the company’s development strategy moving forward after the completion of a leveraged buyout in 2017. Additionally, Goupil shares the CDMO’s innovation capabilities as a leading player in the Blow-fill-seal (BFS) niche. While the continuation of outsourcing by pharmaceutical companies is a trend,…
France Mathilde Lignot-Leloup, director of the French Social Security, provides a fascinating look into the French social system and speaks about its ongoing transformation. She elaborates on change management processes within the social security system, including the pension system while getting back to budget equilibrium expected for 2019 (a first in…
Spain Dr Juan Abarca Cidón, president of HM Hospitales, one of Spain’s leading private health groups, gives insight into the private health sector of the country, its relation to the public system, and the opportunities that exist to interact. Dr Abarca goes on to discuss the R&D capabilities of the group…
Korea Professor Jong In Lim, cyber security specialist and president of the Institute for Cyber Security and Privacy (ICSP) provides his assessment of the current situation for information security in Korea, and how this applies to healthcare data. As one of the national experts in cyber security, could you introduce…
Turkey Yelda Ulu Colin, general manager of GE Healthcare in Turkey, offers her insider take on the country’s city hospitals project, highlighting the strengths of the Turkish PPP model and ultimately offering her view on the state of the Turkish medical devices industry as a whole. Turkey is an important…
UK An unusual characteristic of the UK’s healthcare landscape is that charities fund the vast majority of medical research. According to the Association of Medical Research Charities (AMRC), in 2017, 8 million people donated to medical research charities which funded £1.6bn in research and accounted for 47% of all publicly-funded medical research in…
Opinion Carla Smith is a healthcare thought leader with nearly 30 years’ experience. She champions transformational strategy, governance, and policy in the health sector, particularly in the areas of digital health and health IT. In this article, Ms Smith discusses the massive potential of digital therapeutics in helping patients manage their…
UK Today NHS England have released their long-term plan to ensure the future of the NHS and the continued care of UK patients. The plan is backed by 20.5 billion – the biggest funding settlement in NHS history. Informed by NHS staff and patients, the plan sets out their priorities…
Europe The Top Pharma Markets in Europe for 2016 according to the latest EFPIA figures. Germany leads the way, with a market size of EUR 30.815 billion, followed by France and Italy.
Spain Luis Campo, CEO of GE Healthcare Spain & Portugal, discusses the opportunities and challenges inherent in the Spanish healthcare system and the ways in which GE is collaborating with authorities to bring innovative solutions to Spanish patients. GE Healthcare is pioneering the concept of a hospital Command Centre, learning…
Top 10 2018 has been an exciting year in world health and our team has spanned the globe to bring you in-depth country reports and high profile interviews with leaders from the life science industry. Bringing you a diverse array of insights – from those spearheading the medical cannabis revolution to the…
See our Cookie Privacy Policy Here